InvestorsHub Logo
Followers 34
Posts 3040
Boards Moderated 0
Alias Born 01/26/2011

Re: Pazzo1212 post# 377682

Friday, 10/14/2022 1:13:48 PM

Friday, October 14, 2022 1:13:48 PM

Post# of 462352

4.30 p.m LATE BREAKING ORAL COMMUNICATIONS
4.30 p.m LB8 - Top Line Data of ANAVEX®2-73 (blarcamesine) Randomized, Double-blind, Multicenter, Placebo-controlled Phase 2b/3 in
Patients with Early Alzheimer’s Disease (AD)
Stephen Macfarlane 1
, Timo Grimmer 2
, Terence O’brien 3
, Edward Hammond 4
, Walter Kaufmann 4
, Emmanuel Fadiran 4
, Christopher
Missling 4
1
Hammoncare - Melbourne (Australia), 2
THU Munich - Munich (Germany), 3
Monash University, Alfred Health - Melbourne (Australia), 4
Anavex Life
Sciences - New York (United States)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News